The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy-Reference-Cited by-同舟云学术

The value of cardiac magnetic resonance and distribution of late gadolinium enhancement for risk stratification of sudden cardiac death in patients with hypertrophic cardiomyopathy

Published:2016-07 Issue:1 Volume:68 Page:49-56
ISSN:0914-5087
Container-title:Journal of Cardiology
language:en
Short-container-title:Journal of Cardiology

Author:

Klopotowski Mariusz,Kukula Krzysztof,Malek Lukasz A.,Spiewak Mateusz,Polanska-Skrzypczyk Magdalena,Jamiolkowski Jacek,Dabrowski Maciej,Baranowski Rafal,Klisiewicz Anna,Kusmierczyk Mariusz,Jasinska Anna,Jarmus Ewelina,Kruk Mariusz,Ruzyllo Witold,Witkowski Adam,Chojnowska Lidia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference38 articles.

1. Prevalence of hypertrophic cardiomyopathy in a general population of young adults. Echocardiographic analysis of 4111 subjects in the CARDIA Study. Coronary Artery Risk Development in (Young) Adults;Maron;Circulation,1995

2. 2011 ACCF/AHA guideline for the diagnosis and treatment of hypertrophic cardiomyopathy: executive summary: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines;Gersh;J Am Coll Cardiol,2011

3. Phenotypic overlap in hypertrophic cardiomyopathy: apical hypertrophy, midventricular obstruction, and apical aneurysm;Minami;J Cardiol,2014

4. Hypertrophic cardiomyopathy: an important cause of sudden death;McKenna;Arch Dis Child,1984

5. Hypertrophic cardiomyopathy;Maron;Lancet,2013

Cited by 40 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cardiac magnetic resonance assessment of athletic myocardial fibrosis; Benign bystander or malignant marker?;International Journal of Cardiology;2024-01

2. Application of Cardiovascular Computed Tomography to the Assessment of Patients With Hypertrophic Cardiomyopathy;The American Journal of Cardiology;2023-10

3. Diagnosis and Treatment of Hypertrophic Cardiomyopathy;ABC Heart Fail Cardiomyop;2023-07

4. Left Ventricular Hypertrophy and Ventricular Tachyarrhythmia: The Role of Biomarkers;International Journal of Molecular Sciences;2023-02-15

5. Diretriz Brasileira de Dispositivos Cardíacos Eletrônicos Implantáveis – 2023;Arquivos Brasileiros de Cardiologia;2023-01